NASDAQ:CRSP | Cash Flow Statement | CRISPR Therapeutics AG

Complete source-backed cash-flow history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$91.15M
2026-03-31-$122.93M$4.32M-$108.9M$504,000.00-$410.74M$591.91M
2025-12-31-$130.61M$5.66M-$92.55M$517,000.00$37.2M$116.41M
2025-09-30-$106.44M
2025-06-30-$208.55M
2025-03-31-$136M$4.74M-$53.95M$206,000.00-$19.76M$10.59M
2024-12-31-$37.31M$4.84M-$50.03M$254,000.00$105.83M$16.88M
2024-09-30-$85.94M
2024-06-30-$126.41M
2024-03-31-$116.59M$4.83M$109.75M$721,000.00-$97.8M$305.93M
2023-12-31$89.35M$4.9M-$96.07M$738,000.00-$81.45M$38.94M
2023-09-30-$112.15M
2023-06-30-$77.74M
2023-03-31-$53.07M$5.05M$8.8M$3.06M$117.83M$5.4M
2022-12-31-$110.58M$5.85M-$113.33M$6.19M-$175.53M$2.48M
2022-09-30-$174.55M
2022-06-30-$185.83M
2022-03-31-$179.22M$6.04M-$135.24M$15.35M-$114.52M$10.65M
2021-12-31-$141.25M$6.26M-$86.04M$9.18M-$8.72M$6.3M
2021-09-30-$127.15M
2021-06-30$759.23M
2021-03-31-$113.16M$2.72M-$100.66M$7.02M-$167.9M$225.99M
2020-12-31-$107.04M$2.57M-$81.21M$6.24M-$204.24M$412.63M
2020-09-30-$92.44M
2020-06-30-$79.66M
2020-03-31-$69.73M$2.09M-$52.18M$2.99M-$2.99M$1.13M
2019-12-31$30.54M$1.43M$3.38M$952,000.00$7.06M$304.72M
2019-09-30$138.42M
2019-06-30-$53.7M
2019-03-31-$48.41M$812,000.00-$43.74M$1.1M-$1.1M$25.73M
2018-12-31-$47.59M$945,000.00-$28.37M$1M-$1M$0.00-$1.27M
2018-09-30-$50.71M
2018-06-30-$38.38M
2018-03-31-$28.3M$826,000.00-$22.69M$555,000.00-$555,000.00$125.25M
2017-12-31$141,000.00$806,000.00-$14.84M$205,000.00-$205,000.00$1.28M
2017-09-30-$24.71M
2017-06-30-$22.32M
2017-03-31-$21.48M$720,000.00-$23.41M$3.29M
2016-12-31$17.1M$412,000.00-$16.97M$228,000.00
2016-09-30-$14.68M
2016-06-30-$17.16M
2016-03-31-$8.44M$106,000.00-$10.01M$232,000.00
2015-12-31-$12.27M$59,000.00$69M$503,000.00
2015-09-30-$6.35M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$581.6M$19.48M-$345.01M$914,000.00-$31.81M$426.03M
2024-12-31-$366.25M$19.26M-$142.77M$1.9M-$280.48M$331.98M
2023-12-31-$153.61M$19.84M-$260.38M$9.47M$374.65M$62.66M
2022-12-31-$650.18M$24.17M-$495.74M$37.19M-$258.66M$38.59M
2021-12-31$377.66M$17.95M$538.97M$81.71M-$1.04B$250.95M
2020-12-31-$348.87M$9.18M-$238.37M$18.36M-$541.17M$1.02B
2019-12-31$66.86M$4.73M$56.68M$6.68M$1.33M$430.98M
2018-12-31-$164.98M$3.52M-$96.24M$2.77M-$2.77M$57,000.00$315.93M
2017-12-31-$68.36M$3.02M-$70.09M$7.81M-$8.31M$2.61M
2016-12-31-$23.18M$925,000.00-$52.86M$3.02M$31.88M$183.22M
2015-12-31-$25.5M$127,000.00$59.43M$1.15M
2014-12-31-$7.01M$38,000.00-$4.79M